ZANNES MARIA (President, CEO) received a stock award from BIOAFFINITY TECHNOLOGIES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 4 awards
Filed: 7/6/2023ACC: 0001493152-23-023817
DirectorOfficer· President, CEO
Since Aug 2022
+54.57K
Net shares
Net buyer
$106.3K
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
54.57K acquired
Non-Derivative Transactions4
Common Stock
Direct
Shares
+8.23K
Price / share
$2.28
Trade value
$18.76K
% of position
13.3%
1/1/2023
61.67K→69.89K
Common Stock
Direct
Shares
+9.92K
Price / share
$1.89
Trade value
$18.75K
% of position
14.2%
4/15/2023
69.89K→79.81K
Common Stock
Direct
Shares
+26.18K
Price / share
$1.91
Trade value
$50K
% of position
32.8%
6/6/2023
79.81K→105.99K
Common Stock
Direct
Shares
+10.24K
Price / share
$1.83
Trade value
$18.75K
% of position
9.7%
7/1/2023
105.99K→116.24K
Total
Net shares
+54.57K
Net value
$106.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/1/2023 | A · Award | +8.23K | $2.28 | $18.76K | 13.3% | 61.67K | 69.89K |
| Common Stock Direct | 4/15/2023 | A · Award | +9.92K | $1.89 | $18.75K | 14.2% | 69.89K | 79.81K |
| Common Stock Direct | 6/6/2023 | A · Award | +26.18K | $1.91 | $50K | 32.8% | 79.81K | 105.99K |
| Common Stock Direct | 7/1/2023 | A · Award | +10.24K | $1.83 | $18.75K | 9.7% | 105.99K | 116.24K |
| Total | +54.57K | $106.25K | ||||||
Derivative Transactions0
No derivative transactions reported